Skip to content
  • Patent protection and Biogen’s recent flurry of lawsuits

    WGBH - 07/11/2017

    WGBH’s Morning Edition host Bob Seay spoke with Northeastern law professor and WGBH Legal Analyst Daniel Medwed to discuss the recent efforts by Biogen, a Cambridge-based leader in the life sciences field, to file a flurry of lawsuits against competitors to protect its patents related to its blockbuster multiple sclerosis drug, Tecfidera.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.